UPDATE 1-Inspire Pharma posts narrower-than-expected Q4 loss

* Q4 loss narrows to $0.17, est. -$0.25

* Says sufficient liquidity through fiscal 2009, 2010

* Sees 2009 aggregate revenue $80-$90 mln vs est. $85.5 mln

March 3 (Reuters) - Inspire Pharmaceuticals Inc (ISPH.O) posted a narrower-than-expected quarterly loss, helped by 36 percent jump in revenue, and expects its cash and investments to provide liquidity through fiscal 2009 and into 2010.

For the fourth quarter, the company posted a loss of $9.7 million, or 17 cents a share, compared with a loss of $26.3 million, or 51 cents a share in the year-ago period.

Total revenue rose 36 percent to $18.9 million exceeding analysts' average estimate of $17.6 million.

Inspire said given the current economic and capital-raising environment, it was prioritizing and focusing resources on its late-stage clinical programs and revenue-generating marketed products and forecast 2009 revenue in line with analysts' estimates.

Shares of Inspire Pharmaceuticals closed at $3 Monday on Nasdaq.

For full details of the alerts, please double-click [ID:nWNAB9401] (Reporting by Jennifer Robin Raj in Bangalore; Editing by Amitha Rajan)